| Jessica L Appel, CRNA | |
|
2101 Pease St, Harlingen, TX 78550-8307 | |
| (956) 389-1100 | |
| (956) 389-1800 |
| Full Name | Jessica L Appel |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 2101 Pease St, Harlingen, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114221835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 717592 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Iii Pa | 0042630501 | 335 |
| Arlington Anesthesia Group Pllc | 2860798303 | 33 |
| Northstar Anesthesia Pa | 7315907128 | 290 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Palo Pinto County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841258076 PECOS PAC ID: 5890602759 Enrollment ID: O20031106000393 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Harlingen Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093727455 PECOS PAC ID: 5294637112 Enrollment ID: O20040122000244 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Epic Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740690965 PECOS PAC ID: 5991920779 Enrollment ID: O20140711000450 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Arlington Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023483153 PECOS PAC ID: 2860798303 Enrollment ID: O20160310000125 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Northstar Anesthesia Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Sound Physicians Anesthesiology Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295356277 PECOS PAC ID: 1254751407 Enrollment ID: O20201009000612 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Entity Name | Northstar Anesthesia Iii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356968952 PECOS PAC ID: 0042630501 Enrollment ID: O20201022000080 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica L Appel, CRNA 1702 N Ed Carey Dr, Harlingen, TX 78550-8202 Ph: (956) 423-4589 | Jessica L Appel, CRNA 2101 Pease St, Harlingen, TX 78550-8307 Ph: (956) 389-1100 |
News Archive
With less than three months until its go-live date, District officials say the city's health insurance exchange is already functioning as planned by one important measure: prices. City insurance regulators announced Friday that they have finishing granting approval to the plans set to be offered on the exchange, known as D.C. Health Link, starting Oct. 1. Four insurers are offering 301 different plans, and three of the four lowered their prices from their initial proposals after learning what their competitors were planning to charge (DeBonis, 7/19).
New prediction tools to help health-care providers identify patients at risk of inappropriate prescription opioid use, while allowing safe administration of legitimate pain management to those not at high-risk, are being developed by University of Arizona College of Pharmacy researcher Jenny Lo-Ciganic, PhD.
Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs.
› Verified 8 days ago
Mr. Jose L Garcia Iii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-867-2530 | |
Helen Delores Padgett, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Mr. Rene Lee Acosta, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3202 Tucker Rd, Harlingen, TX 78552 Phone: 956-536-7363 | |
Robin Melinda Woodard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Gonzalo Flores, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Perla C Rufo, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 |